United States · FDA National Drug Code directory
Acyclovir
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 63187-253_9f75bb4a-0416-403f-92bc-a3d0e50457c6
- Product NDC
- 63187-253
- Form
- TABLET
- Composition / generic term
- Acyclovir
- Labeler
- Proficient Rx LP
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20131129
- Source listing expiry
- 20261231
Source-listed ingredients
- ACYCLOVIR — 400 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 15 TABLET in 1 BOTTLE (63187-253-15) · 63187-253-15
- 21 TABLET in 1 BOTTLE (63187-253-21) · 63187-253-21
- 25 TABLET in 1 BOTTLE (63187-253-25) · 63187-253-25
- 30 TABLET in 1 BOTTLE (63187-253-30) · 63187-253-30
- 60 TABLET in 1 BOTTLE (63187-253-60) · 63187-253-60
- 90 TABLET in 1 BOTTLE (63187-253-90) · 63187-253-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →